EVOGENE (EVGN) Stock: Buy, Sell, or Hold?
$0.40
+0.02 (+6.29%)
â˛
5d:
+10.82%
30d:
+1.33%
90d:
-39.26%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (92%)
Quality Score
44/100
Position
FAIR
30-Day Fair Range
$0.34 â $0.41
Position: FAIR
Forward P/E & Valuation
-0.7x
Next 12M consensus est.
Wall Street Target
$2.15
+443.8% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.25 / $0.43
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: EVGN is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When EVGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: EVGN is currently trading at $0.40, which is considered fair relative to its 30-day fair value range of $0.34 to $0.41.
Technical Outlook: Technically, EVGN is in a downtrend. Immediate support is located at $0.25, while resistance sits at $0.43. The stock is showing strong short-term momentum, up 6.3% recently.
Market Sentiment: EVGN scores 62/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $2.15 (+443.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, EVGN is in a downtrend. Immediate support is located at $0.25, while resistance sits at $0.43. The stock is showing strong short-term momentum, up 6.3% recently.
Market Sentiment: EVGN scores 62/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $2.15 (+443.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.34 -
$0.41
Company Quality Score
44/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
92.1%
Trading Range & Key Levels
30-Day Trading Range
$0.34 -
$0.41
Current vs Trading Range
FAIR
Support Level
$0.25
Resistance Level
$0.43
Current Trend
Downtrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (62/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.3%)
- BULLISH: Trading 443.8% below Wall St target ($2.15)
- WARNING: Composite score 44/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-0.66
Wall Street Target
$2.15
(+443.8%)
Revenue Growth (YoY)
-60.7%
Share EVGN Analysis
Share this live EVGN analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (EVGN)
Bullish
2 Retail Mentions
StockTwits Volume
2 msgs
24h retail stream
Last Tracked
Nov 10, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits messages indicate a bullish sentiment towards $EVGN with mentions of increasing volume and potential breakout in relation to $SPY.
Key Retail Themes:
Volume
Breakout
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 3:23 AM ET
Data refreshes hourly during market hours. Next update: 4:23 AM
Data refreshes hourly during market hours. Next update: 4:23 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is EVGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$145 | 31 SELL |
|
ARGX
argenx NV ADR |
STRONG BUY
23 analysts |
$1147 | 35 SELL |
|
BNTX
BioNTech SE |
BUY
21 analysts |
$114 | 62 BUY |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 41 HOLD |
|
RAPP
Rapport Therapeutics, InâĻ |
STRONG BUY
16 analysts |
$64 | 45 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive EVGN Research Pages
